Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2024

14-03-2024 | Acute Myeloid Leukemia | Guideline

JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)

Author: Yoshinobu Maeda

Published in: International Journal of Hematology | Issue 4/2024

Login to get access

Excerpt

Acute myeloid leukemia (AML) is a highly diverse hematologic malignancy characterized by autonomous clonal proliferation of immature myeloid cells that are unable to differentiate or mature normally. Abnormal proliferation of leukemic cells in the bone marrow markedly impairs normal hematopoiesis, causing various symptoms associated with leukopenia, anemia, and thrombocytopenia. It is a serious disease that can lead to death from infection or hemorrhage in a short period of time if not treated properly. …
Metadata
Title
JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)
Author
Yoshinobu Maeda
Publication date
14-03-2024
Publisher
Springer Nature Singapore
Published in
International Journal of Hematology / Issue 4/2024
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-024-03730-2

Other articles of this Issue 4/2024

International Journal of Hematology 4/2024 Go to the issue

Original Article

Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants

Original Article

Predictive factors for l-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia

Original Article

Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth

Images in Hematology

Multiple myeloma presenting as nodular hepatic lesions mimicking hepatocellular carcinoma

Original Article

Decade-long WT1-specific CTLs induced by WT1 peptide vaccination

Original Article

Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits